Disclosed are compounds of formula:
that inhibiting GPBP activity, making them useful as therapeutics in antibody-mediated disorders, drug-resistant cancer, inflammation, protein misfolding and ER stress-mediated disorders, and aberrant apoptosis.
所公开的是式化合物:
该化合物可抑制 GPBP 的活性,从而可用作
抗体介导的疾病、耐药性癌症、炎症、蛋白质错误折叠和 ER 应激介导的疾病以及异常细胞凋亡的治疗药物。